|
Volumn 28, Issue 1 A, 2008, Pages 55-68
|
Effect of pO2 on antitumor drug cytotoxicity on MDR and non-MDR variants selected from the LoVo metastatic colon carcinoma cell line
|
Author keywords
Antioxidants; Cell lines; Colon carcinoma; Multidrug resistance; P glycoprotein
|
Indexed keywords
ANTINEOPLASTIC AGENT;
DOXORUBICIN;
GLYCOPROTEIN P;
LUNG RESISTANCE PROTEIN;
MUCIN 2;
MULTIDRUG RESISTANCE PROTEIN;
TRYPSIN;
VINBLASTINE;
ABCB1 PROTEIN, HUMAN;
ANTIOXIDANT;
MUCIN;
OXYGEN;
SUCRASE ISOMALTASE;
TUMOR MARKER;
UNCLASSIFIED DRUG;
ARTICLE;
CELL ANCHORAGE;
CELL GROWTH;
CELL MEMBRANE;
CELL MEMBRANE PERMEABILITY;
CELL PROLIFERATION;
CHEMOSENSITIVITY;
COLON CARCINOMA;
CONTROLLED STUDY;
CYTOPLASM;
CYTOTOXICITY;
ELECTRON MICROSCOPY;
HUMAN;
HUMAN CELL;
IC 50;
MALE;
METASTASIS;
MUCUS SECRETION;
MULTIDRUG RESISTANCE;
OXYGEN TENSION;
PRIORITY JOURNAL;
BIOSYNTHESIS;
COLON TUMOR;
DRUG EFFECT;
DRUG RESISTANCE;
METABOLISM;
PATHOLOGY;
TUMOR CELL LINE;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
ANTIOXIDANTS;
CELL GROWTH PROCESSES;
CELL LINE, TUMOR;
COLONIC NEOPLASMS;
DOXORUBICIN;
DRUG RESISTANCE, MULTIPLE;
DRUG RESISTANCE, NEOPLASM;
HUMANS;
MUCINS;
OXYGEN;
P-GLYCOPROTEIN;
SUCRASE-ISOMALTASE COMPLEX;
TUMOR MARKERS, BIOLOGICAL;
VINBLASTINE;
|
EID: 40549139094
PISSN: 02507005
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (9)
|
References (81)
|